Names | |
---|---|
Preferred IUPAC name
(2E)-10-Hydroxydec-2-enoic acid | |
Other names
| |
Identifiers | |
3D model (
JSmol)
|
|
ChEBI | |
ChemSpider | |
MeSH | C055543 |
PubChem
CID
|
|
UNII | |
CompTox Dashboard (
EPA)
|
|
| |
| |
Properties | |
C10H18O3 | |
Molar mass | 186.251 g·mol−1 |
Except where otherwise noted, data are given for materials in their
standard state (at 25 °C [77 °F], 100 kPa).
|
Queen bee acid (10-hydroxy-2-decenoic acid or 10-HDA) is a fatty acid found in royal jelly. [1] [2] [3]
Queen bee acid is being investigated for its potential pharmacological activities. It promotes neurogenesis of neural stem/ progenitor cells (cells capable of differentiating into neurons, astrocytes, or oligodendrocytes) in vitro. [4] In addition, queen bee acid has been reported to have in vitro anti-tumor, anti-biotic, immunomodulatory, estrogenic, neurogenic, and innate immune response modulating activities. [5]
In the United States, the Food and Drug Administration has taken legal action against companies that have used unfounded claims of health benefits to market royal jelly products. [6] [7]
Names | |
---|---|
Preferred IUPAC name
(2E)-10-Hydroxydec-2-enoic acid | |
Other names
| |
Identifiers | |
3D model (
JSmol)
|
|
ChEBI | |
ChemSpider | |
MeSH | C055543 |
PubChem
CID
|
|
UNII | |
CompTox Dashboard (
EPA)
|
|
| |
| |
Properties | |
C10H18O3 | |
Molar mass | 186.251 g·mol−1 |
Except where otherwise noted, data are given for materials in their
standard state (at 25 °C [77 °F], 100 kPa).
|
Queen bee acid (10-hydroxy-2-decenoic acid or 10-HDA) is a fatty acid found in royal jelly. [1] [2] [3]
Queen bee acid is being investigated for its potential pharmacological activities. It promotes neurogenesis of neural stem/ progenitor cells (cells capable of differentiating into neurons, astrocytes, or oligodendrocytes) in vitro. [4] In addition, queen bee acid has been reported to have in vitro anti-tumor, anti-biotic, immunomodulatory, estrogenic, neurogenic, and innate immune response modulating activities. [5]
In the United States, the Food and Drug Administration has taken legal action against companies that have used unfounded claims of health benefits to market royal jelly products. [6] [7]